Our goal at EuroCan is to be a leader in the production of high quality, legally approved cannabis products and extracts for medical use in a range of formulations.
EuroCan holds two licences to produce medicinal cannabis.
Lesotho |
Portugal |
|---|---|
| Processing lab | 31 Hectare site |
| GACP certification process commenced | Construction process on-going |
| 2,800 m² (greenhouse) and 800 m² (buildings/facility) – fully constructed |
5,000 m² (greenhouse) and 3,600 m² (ancillary/support building for operations including administration, GMP manufacturing/processing, QC lab, manufacturing and cultivation support services and warehousing) |
Lesotho |
|---|
| Processing lab |
| GACP certification process commenced |
| 2,800 m² (greenhouse) and800 m² (buildings/facility) – fully constructed |
Portugal |
|---|
| 31 Hectare site |
| Construction process on-going |
| 5,000 m² (greenhouse) and 3,600 m² (ancillary/support building for operations including administration, GMP manufacturing/processing, QC lab, manufacturing and cultivation support services and warehousing) |
-
Licenced cannabis cultivation, extraction, manufacture and distribution from our 31 hectare site in Mação, Portugal. *
-
EU grant of Euro 4.3m awarded & part-disbursed (to date).
-
Construction finance facility secured with local bank, Millennium BCP.
-
As at November 2021 Phase 1 construction work is over 25% complete – full completion expected May 2022.
* Subject to completion inspection
- Technoedif engaged as EPC contractor.
- Phase 1 construction will comprise:
5,000 m² of GACP greenhouses
3,600 m² ancillary/support building (including administration,
manufacturing & cultivation support services and warehousing). Completed construction will include a full, on-site GMP extraction lab - Phase 2 construction will extend greenhouses footprint to 20,000 m² (targeted 2024).
PHASE 2: PLANNED PROJECT TO INCREASE TO
20,000 M² OF GREENHOUSES
CONSTRUCTION STATUS
Currently 25% – Full completion
scheduled for May 2022
OUR COMPETENCIES
- R&D programmes both on the agri-tech and cannabinoids field
- Multi-disciplinary team
OUR CONSTRUCTION AND OPERATIONAL OBJECTIVES
- Sustainability with low cost year round production
- State of the art facility and delivery of high quality products
-
Fully licenced to cultivate and manufacture medicinal cannabis.
-
16 Hectare site near airport and next to road infrastructure.
-
5 Greenhouses totalling 2,800 m².
-
Project planned to increase to 20 Greenhouses (10,000 m²).
- GACP audit underway – completion targeted in 2022
- Dried flower production of 1t in 2022,
increasing to 4t by 2024
First sale process underway - GMP certification targeted for Q3 2022
EXPANSION FOOTPRINT
